Managing strategies for lung, head and neck cancer

ESMO 2014: News Roundup

ESMO 2014 Editor's roundup

Prognostic biomarkers will detect lung cancer at earlier stages

Questions raised about the future of lung cancer vaccination?

PD-L1 protein a possible immunotherapy target in mesothelioma

Phase III trial results raise questions about the future of lung cancer vaccination

Little benefit for gefitinib-resistant lung cancer when continuing the drug with chemotherapy

Anamorelin improves appetite and body mass in non-small cell lung cancer with cancer anorexia-cachexia

New drug anamorelin shows improvement in appetite and body mass in non-small cell lung cancer with cancer anorexia-cachexia

Impact of biomarker-integrated approaches of targeted therapy for lung cancer elimination

Proactive P4 medicine making blood a window into health and disease